News

Metastatic Cutaneous Squamous Cell Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight
DelveInsight's "Metastatic Cutaneous Squamous Cell Cancer Market Insights, Epidemiology, and Market Forecast- 2032" report ...
Stocktwits on MSN3h
Summit Therapeutics Retail Traders Stoked As Stock Surges On Promising Cancer Drug Trial
Shares of Summit Therapeutics Inc. (SMMT) surged more than 21% on Wednesday and extended gains in after-hours trading, driven ...
CURE12h
Ivonescimab Plus Chemo May Slow Advanced NSCLC Progression
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting ...
Healio6d
Combination immunotherapy better than single agent in head, neck cancer
Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...
Targeted Oncology7d
Immunotherapy Inches Forward in Head and Neck Cancer Trials
The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...
Cancer Therapy Advisor1d
Neoadjuvant Combo Shows Promise for Penile Cancer
The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.